1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Opioid Pain Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Medical Cannabis Treatment
1.2.3 Capsaicin-derived Treatment
1.2.4 Menthol-containing Treatment
1.2.5 Omega 3 fatty acid-containing Treatment
1.2.6 Botulinum Toxins
1.3 Market by Application
1.3.1 Global Non-Opioid Pain Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Orthopaedic and Musculoskeletal Pain
1.3.3 Neuropathic Pain
1.3.4 Cancer Pain
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-Opioid Pain Treatment Market Perspective (2017-2028)
2.2 Non-Opioid Pain Treatment Growth Trends by Region
2.2.1 Non-Opioid Pain Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Non-Opioid Pain Treatment Historic Market Size by Region (2017-2022)
2.2.3 Non-Opioid Pain Treatment Forecasted Market Size by Region (2023-2028)
2.3 Non-Opioid Pain Treatment Market Dynamics
2.3.1 Non-Opioid Pain Treatment Industry Trends
2.3.2 Non-Opioid Pain Treatment Market Drivers
2.3.3 Non-Opioid Pain Treatment Market Challenges
2.3.4 Non-Opioid Pain Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Opioid Pain Treatment Players by Revenue
3.1.1 Global Top Non-Opioid Pain Treatment Players by Revenue (2017-2022)
3.1.2 Global Non-Opioid Pain Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Non-Opioid Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-Opioid Pain Treatment Revenue
3.4 Global Non-Opioid Pain Treatment Market Concentration Ratio
3.4.1 Global Non-Opioid Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Opioid Pain Treatment Revenue in 2021
3.5 Non-Opioid Pain Treatment Key Players Head office and Area Served
3.6 Key Players Non-Opioid Pain Treatment Product Solution and Service
3.7 Date of Enter into Non-Opioid Pain Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Opioid Pain Treatment Breakdown Data by Type
4.1 Global Non-Opioid Pain Treatment Historic Market Size by Type (2017-2022)
4.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2023-2028)
5 Non-Opioid Pain Treatment Breakdown Data by Application
5.1 Global Non-Opioid Pain Treatment Historic Market Size by Application (2017-2022)
5.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Non-Opioid Pain Treatment Market Size (2017-2028)
6.2 North America Non-Opioid Pain Treatment Market Size by Type
6.2.1 North America Non-Opioid Pain Treatment Market Size by Type (2017-2022)
6.2.2 North America Non-Opioid Pain Treatment Market Size by Type (2023-2028)
6.2.3 North America Non-Opioid Pain Treatment Market Share by Type (2017-2028)
6.3 North America Non-Opioid Pain Treatment Market Size by Application
6.3.1 North America Non-Opioid Pain Treatment Market Size by Application (2017-2022)
6.3.2 North America Non-Opioid Pain Treatment Market Size by Application (2023-2028)
6.3.3 North America Non-Opioid Pain Treatment Market Share by Application (2017-2028)
6.4 North America Non-Opioid Pain Treatment Market Size by Country
6.4.1 North America Non-Opioid Pain Treatment Market Size by Country (2017-2022)
6.4.2 North America Non-Opioid Pain Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Non-Opioid Pain Treatment Market Size (2017-2028)
7.2 Europe Non-Opioid Pain Treatment Market Size by Type
7.2.1 Europe Non-Opioid Pain Treatment Market Size by Type (2017-2022)
7.2.2 Europe Non-Opioid Pain Treatment Market Size by Type (2023-2028)
7.2.3 Europe Non-Opioid Pain Treatment Market Share by Type (2017-2028)
7.3 Europe Non-Opioid Pain Treatment Market Size by Application
7.3.1 Europe Non-Opioid Pain Treatment Market Size by Application (2017-2022)
7.3.2 Europe Non-Opioid Pain Treatment Market Size by Application (2023-2028)
7.3.3 Europe Non-Opioid Pain Treatment Market Share by Application (2017-2028)
7.4 Europe Non-Opioid Pain Treatment Market Size by Country
7.4.1 Europe Non-Opioid Pain Treatment Market Size by Country (2017-2022)
7.4.2 Europe Non-Opioid Pain Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Opioid Pain Treatment Market Size (2017-2028)
8.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type
8.2.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Non-Opioid Pain Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application
8.3.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Non-Opioid Pain Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region
8.4.1 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Non-Opioid Pain Treatment Market Size (2017-2028)
9.2 Latin America Non-Opioid Pain Treatment Market Size by Type
9.2.1 Latin America Non-Opioid Pain Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Non-Opioid Pain Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Non-Opioid Pain Treatment Market Share by Type (2017-2028)
9.3 Latin America Non-Opioid Pain Treatment Market Size by Application
9.3.1 Latin America Non-Opioid Pain Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Non-Opioid Pain Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Non-Opioid Pain Treatment Market Share by Application (2017-2028)
9.4 Latin America Non-Opioid Pain Treatment Market Size by Country
9.4.1 Latin America Non-Opioid Pain Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Non-Opioid Pain Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Opioid Pain Treatment Market Size (2017-2028)
10.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type
10.2.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Non-Opioid Pain Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application
10.3.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Non-Opioid Pain Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country
10.4.1 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan PLC
11.1.1 Allergan PLC Company Details
11.1.2 Allergan PLC Business Overview
11.1.3 Allergan PLC Non-Opioid Pain Treatment Introduction
11.1.4 Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2017-2022)
11.1.5 Allergan PLC Recent Developments
11.2 Canopy Growth
11.2.1 Canopy Growth Company Details
11.2.2 Canopy Growth Business Overview
11.2.3 Canopy Growth Non-Opioid Pain Treatment Introduction
11.2.4 Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2017-2022)
11.2.5 Canopy Growth Recent Developments
11.3 Medical Marijuana Inc.
11.3.1 Medical Marijuana Inc. Company Details
11.3.2 Medical Marijuana Inc. Business Overview
11.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Introduction
11.3.4 Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2017-2022)
11.3.5 Medical Marijuana Inc. Recent Developments
11.4 Panag Pharma Inc.
11.4.1 Panag Pharma Inc. Company Details
11.4.2 Panag Pharma Inc. Business Overview
11.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Introduction
11.4.4 Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2017-2022)
11.4.5 Panag Pharma Inc. Recent Developments
11.5 Tilray
11.5.1 Tilray Company Details
11.5.2 Tilray Business Overview
11.5.3 Tilray Non-Opioid Pain Treatment Introduction
11.5.4 Tilray Revenue in Non-Opioid Pain Treatment Business (2017-2022)
11.5.5 Tilray Recent Developments
11.6 Aphria Inc.
11.6.1 Aphria Inc. Company Details
11.6.2 Aphria Inc. Business Overview
11.6.3 Aphria Inc. Non-Opioid Pain Treatment Introduction
11.6.4 Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2017-2022)
11.6.5 Aphria Inc. Recent Developments
11.7 Bedrocan
11.7.1 Bedrocan Company Details
11.7.2 Bedrocan Business Overview
11.7.3 Bedrocan Non-Opioid Pain Treatment Introduction
11.7.4 Bedrocan Revenue in Non-Opioid Pain Treatment Business (2017-2022)
11.7.5 Bedrocan Recent Developments
11.8 Cara Therapeutics
11.8.1 Cara Therapeutics Company Details
11.8.2 Cara Therapeutics Business Overview
11.8.3 Cara Therapeutics Non-Opioid Pain Treatment Introduction
11.8.4 Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2017-2022)
11.8.5 Cara Therapeutics Recent Developments
11.9 Centrexion Therapeutics
11.9.1 Centrexion Therapeutics Company Details
11.9.2 Centrexion Therapeutics Business Overview
11.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Introduction
11.9.4 Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2017-2022)
11.9.5 Centrexion Therapeutics Recent Developments
11.10 CHT Medical
11.10.1 CHT Medical Company Details
11.10.2 CHT Medical Business Overview
11.10.3 CHT Medical Non-Opioid Pain Treatment Introduction
11.10.4 CHT Medical Revenue in Non-Opioid Pain Treatment Business (2017-2022)
11.10.5 CHT Medical Recent Developments
11.11 Cronos Group
11.11.1 Cronos Group Company Details
11.11.2 Cronos Group Business Overview
11.11.3 Cronos Group Non-Opioid Pain Treatment Introduction
11.11.4 Cronos Group Revenue in Non-Opioid Pain Treatment Business (2017-2022)
11.11.5 Cronos Group Recent Developments
11.12 GW Pharmaceuticals
11.12.1 GW Pharmaceuticals Company Details
11.12.2 GW Pharmaceuticals Business Overview
11.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Introduction
11.12.4 GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2017-2022)
11.12.5 GW Pharmaceuticals Recent Developments
11.13 Medropharm Gmbh
11.13.1 Medropharm Gmbh Company Details
11.13.2 Medropharm Gmbh Business Overview
11.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Introduction
11.13.4 Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2017-2022)
11.13.5 Medropharm Gmbh Recent Developments
11.14 US Worldmeds LLC
11.14.1 US Worldmeds LLC Company Details
11.14.2 US Worldmeds LLC Business Overview
11.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Introduction
11.14.4 US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2017-2022)
11.14.5 US Worldmeds LLC Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Non-Opioid Pain Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Medical Cannabis Treatment
Table 3. Key Players of Capsaicin-derived Treatment
Table 4. Key Players of Menthol-containing Treatment
Table 5. Key Players of Omega 3 fatty acid-containing Treatment
Table 6. Key Players of Botulinum Toxins
Table 7. Global Non-Opioid Pain Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Non-Opioid Pain Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Non-Opioid Pain Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Non-Opioid Pain Treatment Market Share by Region (2017-2022)
Table 11. Global Non-Opioid Pain Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Non-Opioid Pain Treatment Market Share by Region (2023-2028)
Table 13. Non-Opioid Pain Treatment Market Trends
Table 14. Non-Opioid Pain Treatment Market Drivers
Table 15. Non-Opioid Pain Treatment Market Challenges
Table 16. Non-Opioid Pain Treatment Market Restraints
Table 17. Global Non-Opioid Pain Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Non-Opioid Pain Treatment Revenue Share by Players (2017-2022)
Table 19. Global Top Non-Opioid Pain Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Opioid Pain Treatment as of 2021)
Table 20. Ranking of Global Top Non-Opioid Pain Treatment Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Non-Opioid Pain Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Non-Opioid Pain Treatment Product Solution and Service
Table 24. Date of Enter into Non-Opioid Pain Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Non-Opioid Pain Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2017-2022)
Table 28. Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2023-2028)
Table 30. Global Non-Opioid Pain Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Non-Opioid Pain Treatment Revenue Share by Application (2017-2022)
Table 32. Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Non-Opioid Pain Treatment Revenue Share by Application (2023-2028)
Table 34. North America Non-Opioid Pain Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Non-Opioid Pain Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Non-Opioid Pain Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Non-Opioid Pain Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Non-Opioid Pain Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Non-Opioid Pain Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Non-Opioid Pain Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Non-Opioid Pain Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Non-Opioid Pain Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Non-Opioid Pain Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Non-Opioid Pain Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Non-Opioid Pain Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Non-Opioid Pain Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Non-Opioid Pain Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Non-Opioid Pain Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Non-Opioid Pain Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Non-Opioid Pain Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Non-Opioid Pain Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Non-Opioid Pain Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Non-Opioid Pain Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Non-Opioid Pain Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Non-Opioid Pain Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Non-Opioid Pain Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Non-Opioid Pain Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Non-Opioid Pain Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Non-Opioid Pain Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Non-Opioid Pain Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Non-Opioid Pain Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Non-Opioid Pain Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Non-Opioid Pain Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 64. Allergan PLC Company Details
Table 65. Allergan PLC Business Overview
Table 66. Allergan PLC Non-Opioid Pain Treatment Product
Table 67. Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million)
Table 68. Allergan PLC Recent Developments
Table 69. Canopy Growth Company Details
Table 70. Canopy Growth Business Overview
Table 71. Canopy Growth Non-Opioid Pain Treatment Product
Table 72. Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million)
Table 73. Canopy Growth Recent Developments
Table 74. Medical Marijuana Inc. Company Details
Table 75. Medical Marijuana Inc. Business Overview
Table 76. Medical Marijuana Inc. Non-Opioid Pain Treatment Product
Table 77. Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million)
Table 78. Medical Marijuana Inc. Recent Developments
Table 79. Panag Pharma Inc. Company Details
Table 80. Panag Pharma Inc. Business Overview
Table 81. Panag Pharma Inc. Non-Opioid Pain Treatment Product
Table 82. Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million)
Table 83. Panag Pharma Inc. Recent Developments
Table 84. Tilray Company Details
Table 85. Tilray Business Overview
Table 86. Tilray Non-Opioid Pain Treatment Product
Table 87. Tilray Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million)
Table 88. Tilray Recent Developments
Table 89. Aphria Inc. Company Details
Table 90. Aphria Inc. Business Overview
Table 91. Aphria Inc. Non-Opioid Pain Treatment Product
Table 92. Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million)
Table 93. Aphria Inc. Recent Developments
Table 94. Bedrocan Company Details
Table 95. Bedrocan Business Overview
Table 96. Bedrocan Non-Opioid Pain Treatment Product
Table 97. Bedrocan Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million)
Table 98. Bedrocan Recent Developments
Table 99. Cara Therapeutics Company Details
Table 100. Cara Therapeutics Business Overview
Table 101. Cara Therapeutics Non-Opioid Pain Treatment Product
Table 102. Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million)
Table 103. Cara Therapeutics Recent Developments
Table 104. Centrexion Therapeutics Company Details
Table 105. Centrexion Therapeutics Business Overview
Table 106. Centrexion Therapeutics Non-Opioid Pain Treatment Product
Table 107. Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million)
Table 108. Centrexion Therapeutics Recent Developments
Table 109. CHT Medical Company Details
Table 110. CHT Medical Business Overview
Table 111. CHT Medical Non-Opioid Pain Treatment Product
Table 112. CHT Medical Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million)
Table 113. CHT Medical Recent Developments
Table 114. Cronos Group Company Details
Table 115. Cronos Group Business Overview
Table 116. Cronos Group Non-Opioid Pain Treatment Product
Table 117. Cronos Group Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million)
Table 118. Cronos Group Recent Developments
Table 119. GW Pharmaceuticals Company Details
Table 120. GW Pharmaceuticals Business Overview
Table 121. GW Pharmaceuticals Non-Opioid Pain Treatment Product
Table 122. GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million)
Table 123. GW Pharmaceuticals Recent Developments
Table 124. Medropharm Gmbh Company Details
Table 125. Medropharm Gmbh Business Overview
Table 126. Medropharm Gmbh Non-Opioid Pain Treatment Product
Table 127. Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million)
Table 128. Medropharm Gmbh Recent Developments
Table 129. US Worldmeds LLC Company Details
Table 130. US Worldmeds LLC Business Overview
Table 131. US Worldmeds LLC Non-Opioid Pain Treatment Product
Table 132. US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2017-2022) & (US$ Million)
Table 133. US Worldmeds LLC Recent Developments
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Opioid Pain Treatment Market Share by Type: 2021 VS 2028
Figure 2. Medical Cannabis Treatment Features
Figure 3. Capsaicin-derived Treatment Features
Figure 4. Menthol-containing Treatment Features
Figure 5. Omega 3 fatty acid-containing Treatment Features
Figure 6. Botulinum Toxins Features
Figure 7. Global Non-Opioid Pain Treatment Market Share by Application: 2021 VS 2028
Figure 8. Orthopaedic and Musculoskeletal Pain Case Studies
Figure 9. Neuropathic Pain Case Studies
Figure 10. Cancer Pain Case Studies
Figure 11. Others Case Studies
Figure 12. Non-Opioid Pain Treatment Report Years Considered
Figure 13. Global Non-Opioid Pain Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Non-Opioid Pain Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Non-Opioid Pain Treatment Market Share by Region: 2021 VS 2028
Figure 16. Global Non-Opioid Pain Treatment Market Share by Players in 2021
Figure 17. Global Top Non-Opioid Pain Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Opioid Pain Treatment as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Non-Opioid Pain Treatment Revenue in 2021
Figure 19. North America Non-Opioid Pain Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Non-Opioid Pain Treatment Market Size Market Share by Type (2017-2028)
Figure 21. North America Non-Opioid Pain Treatment Market Size Market Share by Application (2017-2028)
Figure 22. North America Non-Opioid Pain Treatment Market Size Share by Country (2017-2028)
Figure 23. United States Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Non-Opioid Pain Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Non-Opioid Pain Treatment Market Size Market Share by Type (2017-2028)
Figure 27. Europe Non-Opioid Pain Treatment Market Size Market Share by Application (2017-2028)
Figure 28. Europe Non-Opioid Pain Treatment Market Size Share by Country (2017-2028)
Figure 29. Germany Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Non-Opioid Pain Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Non-Opioid Pain Treatment Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Non-Opioid Pain Treatment Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Non-Opioid Pain Treatment Market Size Share by Region (2017-2028)
Figure 39. China Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Non-Opioid Pain Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Non-Opioid Pain Treatment Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Non-Opioid Pain Treatment Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Non-Opioid Pain Treatment Market Size Share by Country (2017-2028)
Figure 49. Mexico Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Non-Opioid Pain Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Non-Opioid Pain Treatment Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Non-Opioid Pain Treatment Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Non-Opioid Pain Treatment Market Size Share by Country (2017-2028)
Figure 55. Turkey Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Non-Opioid Pain Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Allergan PLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022)
Figure 59. Canopy Growth Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022)
Figure 60. Medical Marijuana Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022)
Figure 61. Panag Pharma Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022)
Figure 62. Tilray Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022)
Figure 63. Aphria Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022)
Figure 64. Bedrocan Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022)
Figure 65. Cara Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022)
Figure 66. Centrexion Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022)
Figure 67. CHT Medical Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022)
Figure 68. Cronos Group Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022)
Figure 69. GW Pharmaceuticals Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022)
Figure 70. Medropharm Gmbh Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022)
Figure 71. US Worldmeds LLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
